TRYTON SIDE BRANCH STENT

Stent, Coronary

FDA Premarket Approval P150039

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the tryton side branch stent. This device is indicated for improving the side branch luminal diameter of de novo native coronary artery bifurcation lesions (medina classification 1. 1. 1; 0. 1. 1; 1. 0. 1) with a side branch diameter stenosis of >=50% and a lesion length =2. 5 mm to =2. 5 mm to

DeviceTRYTON SIDE BRANCH STENT
Classification NameStent, Coronary
Generic NameStent, Coronary
ApplicantTRYTON MEDICAL, INC.
Date Received2015-10-30
Decision Date2017-02-21
Notice Date2017-02-27
PMAP150039
SupplementS
Product CodeMAF
Docket Number17M-1121
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address TRYTON MEDICAL, INC. 1000 Park 40 Plaza Suite 325 durham, NC 27713
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P150039Original Filing
S005 2020-09-04 Normal 180 Day Track No User Fee
S004 2019-06-07 30-day Notice
S003 2017-09-29 Normal 180 Day Track No User Fee
S002 2017-07-11 30-day Notice
S001 2017-03-13 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00894588002187 P150039 000
00894588002170 P150039 000
00894588002163 P150039 000
00894588002156 P150039 000
00894588002149 P150039 000
00894588002132 P150039 000
00894588002125 P150039 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.